These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9380655)

  • 21. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculin sensitivity and morphological immune response in guinea pigs after application of minimal sensitizing dose of BCG vaccine, substrain Sofia SL222.
    Bachvarova M; Stefanova T; Nikolaeva S; Chouchkova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):1010-5. PubMed ID: 19393344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of BCG vaccines: Polish, Danish and Japanese -- laboratory tests].
    Janaszek W
    Przegl Epidemiol; 1994; 48(3):285-92. PubMed ID: 7938633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
    Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM; Kang L; Wang XH
    Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG vaccine--current status.
    Vijayalakshmi V; Murthy KJ
    J Indian Med Assoc; 2000 Mar; 98(3):110-1, 114. PubMed ID: 11016164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
    Hoft DF; Brown RM; Roodman ST
    J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and development of synthetic peptide vaccines: past, present and future.
    Bijker MS; Melief CJ; Offringa R; van der Burg SH
    Expert Rev Vaccines; 2007 Aug; 6(4):591-603. PubMed ID: 17669012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.
    Xing Z; Charters TJ
    Expert Rev Vaccines; 2007 Aug; 6(4):539-46. PubMed ID: 17669008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New vaccination strategies against tuberculosis].
    Kaufmann HE
    Pneumologie; 1990 Feb; 44 Suppl 1():655-6. PubMed ID: 2114641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG).
    Dorer DE; Czepluch W; Lambeth MR; Dunn AC; Reitinger C; Aldwell FE; McLellan AD
    Cell Microbiol; 2007 Feb; 9(2):544-53. PubMed ID: 17018037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New issues in tuberculosis.
    Kaufmann SH
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii50-ii56. PubMed ID: 15479872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphological study of tuberculin reaction to determine the body responsiveness in tuberculosis].
    Diukanova MIa
    Probl Tuberk; 2003; (3):45-8. PubMed ID: 12744065
    [No Abstract]   [Full Text] [Related]  

  • 38. [CD4+ alpha beta T cell and gamma delta T cell responses to BCG in patients with pulmonary tuberculosis--comparison with healthy controls].
    Tsukaguchi K; Okamura H; Tokuyama T; Okamoto Y; Fu A; Yamamoto C; Nakaya M; Kobayashi A; Yoneda T; Narita N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Dec; 35(12):1330-7. PubMed ID: 9567077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.
    Yao Y; Lai R; Afkhami S; Haddadi S; Zganiacz A; Vahedi F; Ashkar AA; Kaushic C; Jeyanathan M; Xing Z
    J Infect Dis; 2017 Jul; 216(1):135-145. PubMed ID: 28531291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of vaccine-induced resistance in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Dai G; Phalen S
    Tuber Lung Dis; 1999; 79(4):261-6. PubMed ID: 10692995
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.